Reducing the Progression of Coronary Heart Disease With Estradiol
In light of ELITE trial results, estradiol hormone therapy may have a role in coronary heart disease treatment.
All articles by Kathleen Moore, RN
Effects of Idarucizumab on Intracranial Bleeding in Dabigatran-Treated Patients
REVERSE-AD trial’s initial results have demonstrated idarucizumab may function as a reversal agent for dabigatran-treated patients with intracranial hemorrhage.
Untreated Hypertension Associated with 9-Fold or Greater Risk of Intracerebral Hemorrhage
Ethnic/Racial Variations of Intracerebal Variations of Intracerebral Hemorrhage study results indicate hypertension treatment reduces risk of hypertension-related intracerebral hemorrhage.
Pregnancy in Advanced Age May Increase Risk of Hemorrhagic Stroke in Postmenopausal Women
Postmenopausal women whose last pregnancy occurred at 40 years of age or older may have a greater risk of hemorrhagic stroke.
Substrate-Based Ablation Superior to Ablation Targeting Only Clinical and Mappable Ventricular Tachycardias
Substrate-based ablation found superior to ablation targeting only clinical and mappable ventricular tachycardias in patients with ischemic cardiomyopathy.
Fitness in Early Adulthood Associated With Lower Cardiovascular Disease and Mortality
Cardiorespiratory fitness in early adulthood now linked to lower risk of cardiovascular disease and mortality.
Mechanical Thrombectomy Demonstrated Better Outcomes vs Usual Care Alone for Acute Ischemic Stroke
Mechanical thrombectomy after usual care produced better outcomes than usual care alone for acute ischemic stroke caused by large artery occlusion.
Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants
Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.
Next post in Stroke
